-
41
The Immune Response to Tumors as a Tool toward Immunotherapy
Published 2011-01-01“…Herein we will review some of the recent achievement of immunotherapy in such aggressive cancers as melanoma, prostatic cancer, colorectal carcinoma, and hematologic malignancies. …”
Get full text
Article -
42
-
43
Immunotherapy for Hepatocellular Carcinoma: Current Advances and Future Expectations
Published 2018-01-01“…In recent years, tumor immunotherapy has emerged as a promising method owing to its safety and efficacy with respect to delaying the progression of advanced tumors and protecting postoperative patients against tumor relapse and metastasis. …”
Get full text
Article -
44
Structural insights into antibody-based immunotherapy for hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
45
Current trends in peanut allergy immunotherapy: a review
Published 2024-04-01Subjects: Get full text
Article -
46
Targeting T-Cell Activation for Malaria Immunotherapy: Scoping Review
Published 2025-01-01Subjects: Get full text
Article -
47
MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers
Published 2018-01-01“…Since aberrant expressions of miRNAs are found in gastroenterological cancers and miRNAs have been shown to regulate antitumor immunity, the combination therapy combining the traditional antibody-based immunotherapy and novel miRNA-based immunotherapy is promising for achieving clinical success. …”
Get full text
Article -
48
Immunotherapy of Brain Cancers: The Past, the Present, and Future Directions
Published 2010-01-01“…For some patients, immunotherapy has worked for them while not showing long-term toxicity. …”
Get full text
Article -
49
Food allergens and oral immunotherapy as indicators of eosinophilic oesophagitis
Published 2024-05-01“…The main indicators of EoE are food allergens and in recent years the extremely important role of oral immunotherapy (OIT) in the development of this disease has also been increasingly raised. …”
Get full text
Article -
50
Toll-Like Receptor-Based Strategies for Cancer Immunotherapy
Published 2021-01-01“…Altogether, reviewed publications suggest that TLRs make a potential target for the immunotherapy of cancer.…”
Get full text
Article -
51
Anti-cancer immunotherapy-related cardiotoxicity: preventable and treatable
Published 2025-01-01Subjects: “…immunotherapy…”
Get full text
Article -
52
Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
Published 2025-02-01Subjects: “…immunotherapy…”
Get full text
Article -
53
Potential and development of cellular vesicle vaccines in cancer immunotherapy
Published 2025-01-01Subjects: Get full text
Article -
54
Dual Roles of IL-27 in Cancer Biology and Immunotherapy
Published 2017-01-01“…Here, we will summarize IL-27 biological activities and its functional overlaps with the IFNs and discuss its dual role in tumors in the light of potential applications to cancer immunotherapy.…”
Get full text
Article -
55
Recent advances in immunotherapy targeting CETP proteins for atherosclerosis prevention
Published 2025-12-01Subjects: Get full text
Article -
56
Dynamic roles of tumor-infiltrating B lymphocytes in cancer immunotherapy
Published 2025-02-01“…Cancer Immunology, Immunotherapy…”
Get full text
Article -
57
Innovative immunotherapies and emerging treatments in type 1 diabetes management
Published 2025-01-01Subjects: Get full text
Article -
58
Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy
Published 2022-09-01“…Journal for ImmunoTherapy of Cancer…”
Get full text
Article -
59
The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment
Published 2014-01-01“…Most anticancer therapies including immunotherapies are given systemically; yet therapies given directly into tumors may be more effective, particularly those that overcome natural suppressive factors in the tumor microenvironment. …”
Get full text
Article -
60
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
Published 2025-01-01Subjects: “…Cancer immunotherapy…”
Get full text
Article